Recombinant Frataxin anticorps (AA 57-210)
Aperçu rapide pour Recombinant Frataxin anticorps (AA 57-210) (ABIN6939443)
Antigène
Voir toutes Frataxin (FXN) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 57-210
-
Purification
- Purified by Protein A/G
-
Immunogène
- Recombinant human Frataxin protein fragment (around aa 57-210) (exact sequence is proprietary)
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
-
Positive Control: HepG2, HL-60 or HEK293 cells. Pancreas and Liver.
Known Application: ELISA (Use Ab at 2-4 μg/mL for coating) (Order Ab without BSA),Optimal dilution for a specific application should be determined.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-80 °C
-
Stockage commentaire
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Date de péremption
- 24 months
-
-
- Frataxin (FXN)
-
Autre désignation
- FXN
-
Sujet
- Frataxin is a nuclear-encoded mitochondrial protein implicated in Friedreich's ataxia (FRDA), a human autosomal recessive neurodegenerative disease. Lack of Frataxin causes iron to accumulate in the mitochondrial matrix suggesting that Frataxin is involved in mitochondrial iron homeostasis and possibly in iron transport. Frataxin has an alpha-beta fold consisting of two helices flanking an antiparallel beta sheet.
-
Poids moléculaire
- 14kDa
-
ID gène
- 2395
-
UniProt
- Q16595
-
Pathways
- Transition Metal Ion Homeostasis, Regulation of Cell Size
Antigène
-